Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Aptar Pharma Expands its Manufacturing Capacity in New York, USA
Aptar Pharma plans to expand its manufacturing capacity and capabilities in New York, USA This expansion involves a building extension
SK bioscience Expands its Vaccine Manufacturing Facility in Andong, South Korea
SK bioscience plans to expand its vaccine manufacturing facility in Andong, South Korea The expansion enhances manufacturing capabilities for global supply by extending the vaccine
Merck Invests US$324 million (€300 mn) in Daejeon, South Korea
Merck plans to invest US$324 million 300 mn to open new bioprocessing production centre for the development of biologics in Daejeon, South Korea
SCHOTT Pharma Plans to Invest US$371 million in California, USA
SCHOTT Pharma plans to invest US$371 million to open new prefillable syringe manufacturing facility in California, USA
Simtra BioPharma Solutions Invests US$250 million to Construct New Manufactuting Site in Indiana, USA
Simtra BioPharma Solutions invests US$250 million to construct new sterile fillfinish manufacturing site in Indiana, USA
Experic to Open New Facility to Support Clinical Trials & Logistic Services in Ireland, Europe
Experic plans to open new facility to support global clinical trial storage and logistics services in Ireland, Europe
Adare Pharma Solutions Expands its Packaging & Warehousing Capabilities In Italy, Europe
Adare Pharma Solutions plans to expand its packaging and warehousing capabilities at its Pessano facility in Italy, Europe
Pharmascience Invests US$120 million to Expand Sterile Injectable Manufacturing Facility in Canada
Pharmascience invests US$120 million to expand its sterile injectable manufacturing facility in Candiac site
National Resilience Invests US$225 million to Increase Cartridge Fill/Finish Capabilities in Cincinnati, USA
National Resilience plans to invest US$225 million to increase PFS and Cartridge fillfinish capabilities in Cincinnati, USA
Daiichi Sankyo Invests US$1.12 billion (€1 billion) to Expand Innovation Centre in Munich, Germany
Daiichi Sankyo with an investment of US$112 billion plans to expand production and development site in Pfaffenhofen an daer Ilm in Germany
